139 related articles for article (PubMed ID: 36633913)
1. Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis.
Huang DQ; Tamaki N; Lee HW; Park SY; Lee YR; Lee HW; Lim SG; Lim TS; Kurosaki M; Marusawa H; Mashiba T; Kondo M; Uchida Y; Kobashi H; Furuta K; Izumi N; Kim BK; Sinn DH
Hepatology; 2023 May; 77(5):1746-1756. PubMed ID: 36633913
[TBL] [Abstract][Full Text] [Related]
2. Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL.
Lee HW; Park SY; Lee YR; Lee H; Lee JS; Kim SU; Park JY; Kim DY; Ahn SH; Kim BK
Am J Gastroenterol; 2022 Feb; 117(2):288-294. PubMed ID: 34506308
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus DNA levels and overall survival in hepatitis B-related hepatocellular carcinoma patients with low-level viremia.
Kim TS; Sinn DH; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
J Gastroenterol Hepatol; 2019 Nov; 34(11):2028-2035. PubMed ID: 31157456
[TBL] [Abstract][Full Text] [Related]
4. Low Level of Hepatitis B Viremia Compared With Undetectable Viremia Increases the Risk of Hepatocellular Carcinoma in Patients With Untreated Compensated Cirrhosis.
Yang J; Choi WM; Shim JH; Lee D; Kim KM; Lim YS; Lee HC; Choi J
Am J Gastroenterol; 2023 Jun; 118(6):1010-1018. PubMed ID: 36622283
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV-DNA level < 2000 IU/mL.
Lee H; Jang S; Ahn SH; Kim BK
Hepatol Int; 2022 Apr; 16(2):294-305. PubMed ID: 35322374
[TBL] [Abstract][Full Text] [Related]
6. Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment.
Kim JH; Sinn DH; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Hepatology; 2017 Aug; 66(2):335-343. PubMed ID: 28012257
[TBL] [Abstract][Full Text] [Related]
7. Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study.
Yun B; Ahn SH; Oh J; Yoon JH; Kim BK
Eur J Intern Med; 2023 Jan; 107():66-72. PubMed ID: 36347739
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load.
Sinn DH; Lee J; Goo J; Kim K; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Yoo BC; Paik SW
Hepatology; 2015 Sep; 62(3):694-701. PubMed ID: 25963803
[TBL] [Abstract][Full Text] [Related]
9. [Demographic characteristics and associated influencing factors in treated patients with chronic hepatitis B with hypoviremia : a single-center retrospective cross-sectional study].
Li T; Kong Y; Liu YY; Liu TF; Ma AD; Li LQ; Pei ZY; Zhang LY
Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):42-48. PubMed ID: 36948848
[No Abstract] [Full Text] [Related]
10. The clinical effect of antiviral therapy in patients with hepatitis B virus-related decompensated cirrhosis and undetectable DNA.
Lee HA; Lee YS; Jung YK; Kim JH; Yim HJ; Yeon JE; Seo YS; Lee JS; Lee HW; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU
J Gastroenterol Hepatol; 2023 May; 38(5):716-723. PubMed ID: 36681856
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels.
Lee J; Sinn DH; Kim JH; Gwak GY; Kim HS; Jung SH; Paik YH; Choi MS; Lee JH; Koh KC; Yoo BC; Paik SW
J Korean Med Sci; 2015 Nov; 30(11):1618-24. PubMed ID: 26539006
[TBL] [Abstract][Full Text] [Related]
12. Low-level viremia and cirrhotic complications in patients with chronic hepatitis B according to adherence to entecavir.
Lee SB; Jeong J; Park JH; Jung SW; Jeong ID; Bang SJ; Shin JW; Park BR; Park EJ; Park NH
Clin Mol Hepatol; 2020 Jul; 26(3):364-375. PubMed ID: 32466635
[TBL] [Abstract][Full Text] [Related]
13. Effects of Virologic Response to Treatment on Short- and Long-term Outcomes of Patients With Chronic Hepatitis B Virus Infection and Decompensated Cirrhosis.
Jang JW; Choi JY; Kim YS; Yoo JJ; Woo HY; Choi SK; Jun CH; Lee CH; Sohn JH; Tak WY; Lee YR; Han KH
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1954-1963.e3. PubMed ID: 29753085
[TBL] [Abstract][Full Text] [Related]
14. Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status.
Kim MN; Hwang SG; Kim BK; Park JY; Kim DY; Han KH; Kim SU; Ahn SH
Gut Liver; 2019 Mar; 13(2):197-205. PubMed ID: 30602075
[TBL] [Abstract][Full Text] [Related]
15. Antiviral therapy predicts the outcomes following resection of hepatocellular carcinoma in patients negative for HBV DNA: a propensity score matching analysis.
Xu M; Zhou Z; Xu R; Zhang H; Lin N; Zhong Y
World J Surg Oncol; 2019 Mar; 17(1):45. PubMed ID: 30823932
[TBL] [Abstract][Full Text] [Related]
16. Silymarin Synergizes with Antiviral Therapy in Hepatitis B Virus-Related Liver Cirrhosis: A Propensity Score Matching Multi-Institutional Study.
Huang CH; Wu VC; Wang CL; Wu CL; Huang YT; Chang SH
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542062
[TBL] [Abstract][Full Text] [Related]
17. Chronic Hepatitis B Infection with Low Level Viremia Correlates with the Progression of the Liver Disease.
Zhang Q; Peng H; Liu X; Wang H; Du J; Luo X; Ren H; Hu P
J Clin Transl Hepatol; 2021 Dec; 9(6):850-859. PubMed ID: 34966648
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels.
Chang JI; Sinn DH; Cho H; Kim S; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Dig Dis Sci; 2022 Sep; 67(9):4565-4573. PubMed ID: 34800218
[TBL] [Abstract][Full Text] [Related]
19. Association of Prophylactic Anti-Hepatitis B Virus Therapy With Improved Long-term Survival in Patients With Hepatocellular Carcinoma Undergoing Transarterial Therapy.
Jang JW; Yoo SH; Nam HC; Jang BH; Sung Sung PS; Lee W; Kwon JH; Nam SW; Bae SH; Yoon SK; Choi JY
Clin Infect Dis; 2020 Jul; 71(3):546-555. PubMed ID: 31504352
[TBL] [Abstract][Full Text] [Related]
20. Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular Carcinoma.
Li Z; Lei Z; Xia Y; Li J; Wang K; Zhang H; Wan X; Yang T; Zhou W; Wu M; Pawlik TM; Lau WY; Shen F
JAMA Surg; 2018 Oct; 153(10):e182721. PubMed ID: 30073257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
